Probing how proteins pair up inside cells
MIT biologists drilled down into how proteins recognize and bind to one another, informing drug treatments for cancer.
MIT biologists drilled down into how proteins recognize and bind to one another, informing drug treatments for cancer.
Extra chromosome alters chromosomal conformation and DNA accessibility in neural progenitor cells; study establishes senescence as a potentially targetable mechanism for future treatment.
Researchers decipher when and why immune cells fail to respond to immunotherapy, and suggest that T cells need a different kind of prodding in order to re-engage the immune response.
A new RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases.
Udayan Umapathi SM ’17 and Will Langford SM ’14, PhD ’19 are co-founders of a Media Lab spinoff building a full-stack platform to enable automation for genomics and genetic engineering.
A new study shows oxygenic photosynthesis likely evolved between 3.4 and 2.9 billion years ago.
MIT professors Dave Des Marais and Caroline Uhler combine plant biology and machine learning to identify genetic roots of plant responses to environmental stress.
Researchers find RNA-guided enzymes are more diverse and widespread than previously believed.
Through a summer research program at MIT, Patricia Pujols explored the neuromuscular junction, and a future in science.
Using a combination of stem cell biology, systems biology, synthetic biology, and chromatin engineering, the Galloway lab will define the molecular regulatory rules of cell-fate transitions.
Professor Laurie Boyer studies cardiac development, and how we might be able to mend broken hearts.
A technique for labeling and retrieving DNA data files from a large pool could help make DNA data storage feasible.
MIT researchers have determined the virus’ protein-coding gene set and analyzed new mutations’ likelihood of helping the virus adapt.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Study suggests this process for eliminating unneeded cells may also protect against cancer.